Perbedaan Multi Spunindo Jaya Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Multi Spunindo Jaya Tbk. diperdagangkan di Rp825 (kapitalisasi pasar 5,24 T, volume 24 jam 16,9 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Multi Spunindo Jaya Tbk. jauh lebih besar — sekitar 31,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Multi Spunindo Jaya Tbk. lebih aktif diperdagangkan (16,9 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MSJA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 5,24 T | 166,01 M |
Volume | 16,9 jt | 324 rb |
Lot | 169,01 rb | 3,24 rb |
Perputaran | 13,99 M | 77,68 jt |
Harga Rata-rata | 827,58 | 239,75 |
Nilai Transaksi | 13,99 M | 77,68 jt |
Harga Ekuilibrium Indikatif | 825 | 240 |
Volume Ekuilibrium Indikatif | 1,8 rb | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Multi Spunindo Jaya Tbk (the Company), was established based on Notarial Deed of WahyudiSuyanto, S.H., No. 102 dated March 7, 1997. The Company started its commercial operation in 1999. The Company’s immediate parent company is PT Maju Selaras Jayamerta and the ultimate controlling shareholder of the Company is Sasongko Basuki.
Selengkapnya di halaman MSJA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →